AJP - Heart AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 296: H1705-H1720, 2009. First published April 10, 2009; doi:10.1152/ajpheart.00162.2009
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/6/H1705    most recent
00162.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Google Scholar
Right arrow Articles by Peart, J. N.
Right arrow Articles by Headrick, J. P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peart, J. N.
Right arrow Articles by Headrick, J. P.

REVIEW

Clinical cardioprotection and the value of conditioning responses

Jason N. Peart and John P. Headrick

Heart Foundation Research Centre, Griffith University, Queensland, Australia

Submitted 19 February 2009 ; accepted in final form 6 April 2009

ABSTRACT

Adjunctive cardioprotective strategies for ameliorating the reversible and irreversible injuries with ischemia-reperfusion (I/R) are highly desirable. However, after decades of research, the promise of clinical cardioprotection from I/R injury remains poorly realized. This may arise from the challenges of trialing and effectively translating experimental findings from laboratory models to patients. One can additionally consider whether features of the more heavily focused upon candidates could limit or preclude therapeutic utility and thus whether we might shift attention to alternate strategies. The phenomena of preconditioning and postconditioning have proven fertile in identification of experimental means of cardioprotection and are the most intensely interrogated responses in the field. However, there is evidence these processes, which share common molecular signaling elements and end effectors, may be poor choices for clinical exploitation. This includes evidence of age dependence, limiting efficacy in target aged or senescent hearts; refractoriness to conditioning stimuli in diseased myocardium; interference from a variety of relevant pharmaceuticals; inadvertent induction of these responses by prior ischemia or commonly used drugs, precluding further benefit; and sex dependence of protective signaling. This review focuses on these features, raising questions about current research strategies, and the suitability of these widely studied phenomena as rational candidates for clinical translation.

acute myocardial infarction; aging; cardiac ischemia; clinical translation; diabetes; obesity; preconditioning; postconditioning; reperfusion



Address for reprint requests and other correspondence: J. N. Peart, Heart Foundation Research Centre, Griffith Univ., PMB 50 Gold Coast Mail Centre, QLD, 9726, Australia (e-mail: j.peart{at}griffith.edu.au)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Heusch and R. Schulz
Neglect of the coronary circulation: some critical remarks on problems in the translation of cardioprotection
Cardiovasc Res, October 1, 2009; 84(1): 11 - 14.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.